Clinical Trials Logo

Laparoscopic Cholecystectomy clinical trials

View clinical trials related to Laparoscopic Cholecystectomy.

Filter by:

NCT ID: NCT06008262 Enrolling by invitation - Clinical trials for Postoperative Nausea and Vomiting

Cold Application Effects on Nausea and Vomiting After Laparoscopic Cholecystectomy

Start date: July 3, 2023
Phase: N/A
Study type: Interventional

This clinical trial aims to test the effect of cold application on postoperative nausea and vomiting.

NCT ID: NCT06008002 Not yet recruiting - Postoperative Pain Clinical Trials

Evaluation of the Efficacy of Regional Anaesthesia for Analgesia After Laparoscopic Cholecystectomy

Start date: August 25, 2023
Phase: N/A
Study type: Interventional

Postoperative pain is important for patient comfort, wound healing and earlier mobilisation. Different procedures are used by clinicians for this purpose. Intravenous and regional anaesthesia techniques can be used for this purpose in patients undergoing laparoscopic cholecystectomy.

NCT ID: NCT05998317 Completed - Postoperative Pain Clinical Trials

Dexamethasone at Night vs at Induction on PONV After Laparoscopic Cholecystectomy

Start date: October 8, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

Since the peak effect of the dexamethasone is delayed to 12-16 hours after iv administration, we designed this study to investigate the effect of administering dexamethasone at-night before surgery versus at-induction (the standard timing) in prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. A pilot randomized controlled study (60 cases) will be started to explore the potential difference, ensure correct and rigorous data collection, and calculate the sample size for a larger pragmatic trial.

NCT ID: NCT05988671 Recruiting - Clinical trials for Postoperative Nausea and Vomiting

Intraperitoneal Dexamethasone, Dexmedetomidine, and Dexamethasone-Dexmedetomidine Combination on Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy

Start date: August 10, 2023
Phase: Phase 3
Study type: Interventional

Nausea and vomiting are some of the most common complaints of patients after any anesthesia, which is often associated with postop-erative pain. The double-blind clinical trial study aimed to compare the prophylactic effect of dexamethasone and dexmedetomidine and their combination in reducing postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy.

NCT ID: NCT05951374 Completed - Clinical trials for Laparoscopic Cholecystectomy

Madany Triangle; a New Era of Laparoscopic Cholecystectomy

Start date: December 1, 2019
Phase:
Study type: Observational

Laparoscopic cholecystectomy has an increased incidence of extrahepatic biliary injury or bleeding. The common hepatic duct is on the medial border of the Calot triangle and at risk of injury. So, The investigators describe a new safety triangle with a more critical view of safety that is far from dangerous. Retrospectively, from December 2019 until March 2023, the investigators will review the medical records for patients who underwent laparoscopic cholecystectomy. The patients underwent cholecystectomy using a new technique in approaches to critical safety with recorded video and available follow up data were included. The patients who had intraoperatively extensive gallbladder adhesion that interfere with the dissection in this area, improper visualization of the cystic duct, patients whose did not operate by this new technique and patients whose have not video record of laparoscopic cholecystectomy will excluded from the study.

NCT ID: NCT05937282 Recruiting - Dexmedetomidine Clinical Trials

Hemodynamic Responses of Dexmedetomidine, Lidocaine or Propofol Infusions During Laparoscopic Cholecystectomy

Start date: July 1, 2023
Phase: Phase 4
Study type: Interventional

This study will be carried out to compare the efficacy of dexmedetomidine, propofol or lidocaine infusions in attenuation of hemodynamic responses to pneumoperitoneum during adult laparoscopic cholecystectomy using electrical cardiometry.

NCT ID: NCT05884268 Not yet recruiting - Clinical trials for Laparoscopic Cholecystectomy

Venlafaxine for Postoperative Pain of Laparoscopic Cholecystectomy

Start date: May 30, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

Recent studies on the impact of perioperative venlafaxine for treatment of acute postoperative pain have yielded positive outcomes . The aim of the present study is to investigate the role of perioperative venlafaxine on the management of postoperative pain in patients undergoing LC.

NCT ID: NCT05871424 Completed - Clinical trials for Laparoscopic Cholecystectomy

Transdermal Buprenorphine Patch for Laparoscopic Cholecystectomy

Start date: June 11, 2023
Phase: N/A
Study type: Interventional

Preliminary studies of the transdermal buprenorphine patch target chronic pain patients, and the pain relief effect and safety have been proven. There are previous reports that the transdermal buprenorphine patch is effective in acute postoperative pain control. However, no clinical studies have yet been reported on its application during laparoscopic cholecystectomy. Therefore, we designed this study to see if the use of a transdermal buprenorphine patch resulted in a better pain profile.

NCT ID: NCT05794503 Recruiting - Clinical trials for Neuromuscular Blockade

Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex

Start date: September 11, 2023
Phase: Early Phase 1
Study type: Interventional

This study is intended to be a single-site, prospective, randomized, controlled study that intends to enroll a total of 230 patients undergoing laparoscopic cholecystectomy at Parkland Hospital. Patients will be randomized to receive either neostigmine or sugammadex for reversal of rocuronium-induced neuromuscular blockade. A standardized anesthetic protocol that is usual and customary for the type of operation the patient is having will be provided to the anesthesia teams of enrolled subjects. The remainder of the anesthetic care of the subject will not deviate from the standard of care. To account for protocol deviations and patient dropout, up to 250 randomization envelopes will be made and enrollment will continue until there are 230 completed enrollments.

NCT ID: NCT05755815 Completed - Clinical trials for Laparoscopic Cholecystectomy

Retrolaminar Block Versus Intraperitoneal Block for Laparoscopic Cholecystectomy

Start date: May 21, 2023
Phase: N/A
Study type: Interventional

Although laparoscopic cholecystectomy is a minimally invasive surgery, it causes moderate-severe pain. The aim of this study is to assess the quality of pain relief in patients who will undergo in laparoscopic cholecystectomy surgery receiving either retrolaminar block or peritoneal block by comparing and evaluating the differences between the two techniques. It is hypothesized that retrolaminar block will be comparable to peritoneal block as a promising effective alternative for analgesia for in laparoscopic cholecystectomy surgeries with fewer side effects.